Invesco Ltd. Stock
Invesco Ltd. Stock
Pros and Cons of Invesco Ltd. in the next few years
Pros
Cons
Performance of Invesco Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Invesco Ltd. | -1.320% | -2.121% | 12.495% | 38.241% | 11.716% | 71.580% | 25.987% |
| Federated Investors Inc. | 1.940% | 1.980% | 5.533% | 23.206% | 13.436% | 57.975% | 89.338% |
| Ares Management L.P | -0.270% | 5.816% | 17.468% | -30.506% | -21.584% | 24.444% | 96.281% |
| Affiliated Managers Group | 1.890% | -0.625% | 6.711% | 74.725% | 29.268% | 156.452% | 144.615% |

sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Invesco Ltd. (IVZ) demonstrates a stable financial position with some positive trends in its latest quarterly report (Q2 2025). Key findings include:
The overall financial trend appears positive, driven by revenue growth and improved profitability.
The company shows improving profitability due to better cost management and revenue growth.
Comments
News
Invesco Q2 Earnings Call Highlights
Key Points
- Interested in Invesco Ltd.? Here are five stocks we like better.
- Invesco reported record growth in the second quarter, with $45.1 billion in net long-term inflows, assets under
Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ
The Vanguard Health Care ETF (NYSEMKT:VHT) offers broad sector exposure and lower costs, while the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) provides a concentrated, higher-volatility play on
This ETF Is Down 7% From Its High. History Says Now Is a Smart Time to Invest.
Although the Invesco Nasdaq 100 ETF (NASDAQ: QQQM) has had a good year so far, up 12.7% year to date through July 23, the past month or so hasn't been the best, with it down over 7% from its June


